None listed
Conditions
Interventions
Drug : Experimental group take Bojungikki-tang granules dissolved water orally 1 pack(7.5g) tid, for 8 week. Control group would not take Bojungikki-tang granules but other conditions are same with
Sponsors
Comprehensive and Integrative Medical Institute
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients with cervical cancer who have received chemoradiation before 1-6 month. 2. ECOG performance 0-2 3. Age: 30-70 4. No disability of cognitive function 5. Patients who can be possible to follow up during this study 6. Patients who have signed an approved informed consent
Exclusion criteria
Exclusion criteria: 1. Patietns who have a history of hypersensitivity after taking Bojungikki-tang granules. 2. Patients who have an autoimmune diseases such as rheumatoid arthritis, Hashimoto's thyroiditis , Bechet's disease , etc. 3. Diabetes 4. Patients who have significant psychiatric history or currently suffering from such diseases. 5. Severe liver or kidney failure at liver and kidney function test. 6. Patients who have alcohol or drug abuse history 7. Patients who did not signe an approved informed consent. 8. Patients who are not suitable for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in CD 3, CD 4, CD 8, CD 19, CD 56 | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life with EORTC( European Organization for Research and Treatment of Cancer) QLQ-30, FSS(Fatigue severity scale);Complete Blood Count, Blood chemical test | — |
Countries
Korea, Republic of
Contacts
Public Contactchoi suk
Daegu Catholic Univercity Medical Center
Outcome results
None listed